Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Equity Ratio (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Equity Ratio for 4 consecutive years, with 0.87 as the latest value for Q4 2025.

  • For Q4 2025, Equity Ratio rose 0.7% year-over-year to 0.87; the TTM value through Dec 2025 reached 0.87, up 0.7%, while the annual FY2025 figure was 0.87, 0.7% up from the prior year.
  • Equity Ratio was 0.87 for Q4 2025 at Day One Biopharmaceuticals, down from 0.88 in the prior quarter.
  • The five-year high for Equity Ratio was 0.97 in Q1 2022, with the low at 0.77 in Q2 2024.
  • Historically, Equity Ratio has averaged 0.91 across 4 years, with a median of 0.92 in 2023.
  • The largest annual shift saw Equity Ratio decreased 18.96% in 2024 before it rose 15.91% in 2025.
  • Over 4 years, Equity Ratio stood at 0.95 in 2022, then dropped by 3.12% to 0.92 in 2023, then fell by 6.39% to 0.86 in 2024, then grew by 0.7% to 0.87 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.87 in Q4 2025, 0.88 in Q3 2025, and 0.89 in Q2 2025.